Why Bay Area's XOMA Surged 700% in 2017 by Not Making Drugs
The company burned through $1.2B and never brought a drug to market in its 37 years. Source: BioSpace
The company burned through $1.2B and never brought a drug to market in its 37 years. Source: BioSpace
Based in Toronto, Ontario, Fibrocor Therapeutics was launched in January 2017. Source: BioSpace
The drug is the first available FDA-approved Peptide Receptor Radionuclide Therapy. Source: BioSpace
Novelion will slash an unknown number of jobs as it initiates "significant cost reduction plans." Source: BioSpace
Astra has Glaxo and its COPD treatment Trelegy Ellipta squarely in its sights. Source: BioSpace
Joseph Jimenez retires at the end of the month after eight years in the top job at Novartis. Source: BioSpace
Another experimental Alzheimer's disease treatment has failed in a late-stage study. Source: BioSpace
The effort was announced last week by the Henri A. Termeer Tribute Committee. Source: BioSpace
Immune-Onc Therapeutics launched in September 2016 and is headquartered in Palo Alto, California. Source: BioSpace
Lilly finally revealed the data in the New England Journal of Medicine. Source: BioSpace